Utilization of Antidiabetic Drugs During Pregnancy: A CDM Pilot Project

Utilization of Antidiabetic Drugs During Pregnancy: A CDM Pilot Project

Utilization of Antidiabetic Drugs During Pregnancy: A CDM Pilot Project

HC0083_OS007_CDM

Overview

Background
  • The prevalence of gestational diabetes has been increasing over the past two decades along with an increase in exposure to antidiabetic drugs during pregnancy.
  • The Food and Drug Administration Sentinel Initiative recently published a study describing the use of antidiabetic drugs across the US, however, the use in Canada is unkown.
Objectives
  • The objective of this pilot project is to determine the utilization of antidiabetic drugs among pregnant people living in Canada using CNODES’ adaptation of the Sentinel Common Data Model.

Manuscripts

Presentations

Project Team

Project Lead
Michael Paterson MSc
Methods Lead
Robert W. Platt PhD
Content Expert
Oriana Yu MD, MSc
Project Manager
Carolina Moriello MSc
Site Investigator
Donica Janzen PhD
Saskatchewan
Site Investigator
Michael Paterson MSc
Ontario
Site Investigator
Sherif Eltonsy MSc, PhD
Manitoba
Site Investigator
Colin R. Dormuth ScD
British Columbia
Analyst
Xinya Lu PhD
Saskatchewan
Analyst
Fangyun Wu MSc
Ontario
Analyst
Matthew Dahl BSc
Manitoba
Analyst
Sean Burnett MA, Econ
British Columbia